Home > Insider Trading > Filing (0001209191-15-079468)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876343	Biotime Inc	BTX	Biological Products, (No Disgnostic Substances) (2836)	943127919

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229339	D Alfred Kingsley	150 E. 57Th Street New York NY 10022	See Remarks	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, No Par Value	Disposition	2015-11-06	100,000	$3.83	5,938,055	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares, No Par Value	1,506,905	Indirect	By Greenbelt Corp.
Common Shares, No Par Value	375,351	Indirect	By Greenway Partners, LP

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Option to Purchase Common Shares	$3.57	2020-06-30	50,000	50,000	Direct
Common Shares	Option to Purchase Common Shares	$3.11	2019-06-30	50,000	50,000	Direct
Common Shares	Option to Purchase Common Shares	$4.13	2018-06-30	50,000	50,000	Direct
Common Shares	Option to Purchase Common Shares	$4.60	2017-06-30	50,000	50,000	Direct
Common Shares	Option to Purchase Common Shares	$5.13	2016-06-30	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2020-06-30	50,000	50,000	Direct
2019-06-30	50,000	50,000	Direct
2018-06-30	50,000	50,000	Direct
2017-06-30	50,000	50,000	Direct
2016-06-30	50,000	50,000	Direct

Footnotes

The securities were sold in a private transaction. Mr. Kingsley plans to invest the sale proceeds in Ascendance Biotechnology, Inc., a new subsidiary of BioTime.
Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.
12,500 options became exercisable on September 30, 2015 and the remaining 37,500 options will become exercisable in 3 equal quarterly installments based upon continued service on the board of directors.
12,500 options became exercisable on September 30, 2014; December 31, 2014; March 31, 2015; and June 30, 2015.
12,500 options became exercisable on September 30, 2013; December 31, 2013; March 31, 2014; and June 30, 2014.
12,500 options became exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013.
12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.